IKENNA ILOKA: Open Payments
NPI 1063933356 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 47 payments from 6 companies in 2025. Trend: 2023 $589 · 2024 $259 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $307 |
| Lundbeck LLC | 12 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $99 |
| Supernus Pharmaceuticals, Inc. | 6 | $91 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Qelbree, Auvelity.
Industry payments across MD — which companies pay providers there.
